Riley

Slovenia
|
2026-2027
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Hantavirus
  • Blood sample

ReBIHI

Germany
|
2019
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Hantavirus
  • Puumala virus
  • Blood sample

Byrne

Ireland
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Hospital
  • Monkeypox virus
  • Blood sample
  • Vaccination
  • MVA-BN

Prats

France
|
2022-2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital
  • Infectious diseases unit
  • Monkeypox virus

Wiedemann

France
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Vaccination
  • MVA-BN

Mico-Cerda

Spain
|
2013-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Respiratory syncytial virus

Jiménez-Nogueira

Spain
|
2020-2023
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus

Okay

Türkiye
|
2021-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Respiratory syncytial virus

Rupp

Switzerland
|
2009-2023
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus

Ezpeleta

Spain
|
2023-2023
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

Ocana de Sentuary

France
|
2023-2024
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

Coma

Spain
|
2023-2024
  • General population
  • Infants (<1 year)
  • Hospital
  • Primary care
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab